TrialClinical pharmacology in drug development2020

Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled Study.

Xia Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.